Evidence map›Paper›PMID 16530324›Full record

ReviewCancer letters2006

The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage.

Junqing Zhou, Chang Uk Lim, Jian Jian Li, Lu Cai, Ying Zhang

Abstract readReview
In one paragraph

Review in Cancer letters, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Cellular Response to Ionizing Radiation: A MicroRNA Story.International journal of molecular and cellular medicine · 2012
    Review
  13. Phosphatases in the cellular response to DNA damage.Cell communication and signaling : CCS · 2010
    Article
  14. Article
  15. Article
  16. AsSIRTing the DNA damage response.Trends in cell biology · 2008
    Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Junqing ZhouDepartment of Environmental and Radiological Health Science, Colorado State University, Fort Collins, CO 80521, USA.
Chang Uk Lim
Jian Jian Li
Lu Cai
Ying Zhang
Colorado State University · USAlbany Research Institute · USPurdue University West Lafayette · USUniversity of Louisville · US

Funding

Role of MnSOD in Acquired Resistance to Cancer TherapyR01CA101990 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI LI, JIAN JIAN · 2004 to 2008
$985k
NCI NIH HHS R01 CA 101990NCI NIH HHS R01 CA101990
6 · The paper itself

Abstract

Ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) kinases have been considered the primary activators of the cellular response to DNA damage. They belong to the protein kinase family, phosphoinositide 3-kinase-related kinase (PIKKs). In human beings, deficiency of these kinases leads to hereditary diseases, namely ataxia telangiectasia (AT) with ATM deficiency and ATR-Seckel with ATR deficiency. NBS1, a component of MRE11/RAD50/NBS1 (MRN) complex, is another important player in DNA damage response (DDR). Mutations of NBS1 are responsible for Nijmegen breakage syndrome (NBS), a human hereditary disease with the characteristics that almost encompassed those of AT and ATR-Seckel. NBS1 has been conventionally thought to be a downstream substrate of ATM and ATR in DDR; however, recent studies suggest that NBS1/MRN functions upstream of both ATM and ATR by recruiting them to the proximity of DNA damage sites and activating their functions. In this mini-review, we would emphasize the requirement of NBS1 as an upstream mediator for the modulation of PIKK family proteins ATM and ATR.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA DamageDNA RepairHumansModels, BiologicalNuclear ProteinsProtein Serine-Threonine KinasesTumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanCell Cycle ProteinsDNA-Binding ProteinsNBN protein, humanNuclear ProteinsProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID16530324
PMCPMC3658610
OpenAlexW2160680368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.